JSC “Kalceks” launches Dexketoprofen solution for injections
JSC “Kalceks” starts production and commercialization of Dexketoprofen 25 mg/ml 2 ml solution for injections. Product has been recently approved via decentralized registration procedure involving seven European Union countries. First sales are expected in Baltic States – Latvia, Lithuania and Estonia, where it is already available under name Dexketoprofen Kalceks, then in Poland and Bulgaria under brand name Auxilen®, as well as in Romania where it will be commercialized under brand name Xedofen®.
Medicinal product contains active ingredient Dexketoprofen trometamol and is indicated for symptomatic treatment of acute pain of moderate to severe intensity, when oral administration is not appropriate such as post-operative pain, renal colic and low back pain.
After initial launch JSC “Kalceks” plans to expand commercialization of this product to three more European Union countries via repeat use registration procedure and to register it nationally in CIS region countries.